tiprankstipranks
Trending News
More News >
4D Molecular Therapeutics (FDMT)
NASDAQ:FDMT
US Market

4D Molecular Therapeutics (FDMT) Ownership - Who Owns 4D Molecular Therapeutics?

Compare
374 Followers

4D Molecular Therapeutics (FDMT) Ownership Overview

12.35%12.31%34.38%10.80%30.16%
12.35% Insiders
34.38% Other Institutional Investors
10.80% ETFs
30.16% Public Companies and Individual Investors
The ownership structure of 4D Molecular Therapeutics (FDMT) stock is a mix of institutional, retail, and individual investors. Approximately 57.49% of the company’s stock is owned by Institutional Investors, 12.35% is owned by Insiders, and 30.16% is owned by Public Companies and Individual Investors.
The ownership structure of 4D Molecular Therapeutics (FDMT) stock is a mix of institutional, retail, and individual investors. Approximately 46.69% of the company’s stock is owned by Institutional Investors, 12.35% is owned by Insiders, and 10.80% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2025
xxxxxxxxxxxxx
$139148

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
4,563,211Institution9.85%18,663,533
4,563,211Insider9.85%18,663,533
2,934,914Institution6.34%12,003,798
2,395,462Institution5.17%9,797,440
2,062,857Institution4.45%8,437,085
2,033,575Institution4.39%8,317,322
1,059,153Insider2.29%4,331,936
952,085Institution2.06%3,894,028
546,322Institution1.18%2,234,457
355,720Institution0.77%1,454,895

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,033,575Institution4.39%8,317,322
952,085Institution2.06%3,894,028
546,322Institution1.18%2,234,457
355,720Institution0.77%1,454,895
328,501Institution0.71%1,343,569
276,537Institution0.60%1,131,036
182,230Institution0.39%745,321
178,607Institution0.39%730,503
158,842Institution0.34%649,664
130,435Institution0.28%533,479

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,537,368Institution3.32%5,565,272
1,154,703Institution2.49%4,792,017
496,207Institution1.07%1,796,269
247,174Institution0.53%1,025,772
239,859Institution0.52%995,415
225,438Institution0.49%816,086
158,522Institution0.34%692,741
154,956Institution0.33%643,067
96,342Institution0.21%348,758
90,574Institution0.20%375,882

FAQ

Who Owns 4D Molecular Therapeutics (FDMT)?
According to the latest TipRanks data, approximately 34.38% of the company's stock is held by institutional investors, 12.35% is held by insiders, and 30.16% is held by retail investors.
    What percentage of 4D Molecular Therapeutics (FDMT) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 34.38% of 4D Molecular Therapeutics (FDMT) stock is held by institutional investors.
      What percentage of 4D Molecular Therapeutics (FDMT) stock is held by retail investors?
      According to the latest TipRanks data, approximately 30.16% of 4D Molecular Therapeutics (FDMT) stock is held by retail investors.
        Who owns the most shares of 4D Molecular Therapeutics (FDMT)?
        Peter Kolchinsky owns the most shares of 4D Molecular Therapeutics (FDMT).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis